EMA Management Board: Highlights of October 2023 meeting
Date: November 27, 2023
The EMA’s Management Board met on 5 October in Amsterdam. The article below covers the highlights discussed in the meeting, including:
- Clinical trials in the EU
- Mid-year report 2023
- EMA HR Strategy
- Covid-19
Read in full here.
Explore More News

New MHRA Guidance
The MHRA have published new guidance on ‘Software and Artificial Intelligence (AI) as a . . .
Read More

FDA Guidance for Industry
The FDA has issued a final guidance to provide information on risk-based approaches to . . .
Read More

Guideline on computerised systems and electronic data in clinical trials
The European Medicines Agency (EMA) have published the new guidelines on computerised . . .
Read More

Welcome IROS – Insights Research Organization & Solutions as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome IROS – Insights . . .
Read More

Recommendation paper on decentralised elements in clinical trials
Following their meeting on 4 Oct, the EMA/HTAs and EC have published a recommendation . . .
Read More

Welcome George Clinical as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome George Clinical . . .
Read More

Welcome Clinion as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Clinion as a . . .
Read More

Welcome ClinoSol Research as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome ClinoSol . . .
Read More

CTU DMEG Update
The CTU DMEG has been actively discussing common problems that data managers face in . . .
Read More

ICH E8 (R1) General Considerations for Clinical Studies Impact on Data Management
The ACDM Regulatory Considerations have reviewed the Revision 1 to the ICH E8 Guidelines . . .
Read More

ACDM Comments on “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations; Draft Guidance for Industry, Investigators, and Other Stakeholders; Availability”
https://acdmglobal.org/wp-content/uploads/2022/04/ACDM_FDA_DHT.pdf
Read More

Have your say – MHRA’s public consultation on proposals for legislative changes for clinical trials
Dear Colleague,
We have just launched our 8-week public consultation on proposals for . . .
Read More